News Releases

Array BioPharma To Present At The Leerink Partners Annual Global Healthcare Conference

BOULDER, Colo., Feb. 2, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Partners Annual Global Healthcare Conference in New York.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Array BioPharma.



Leerink Partners Annual Global Healthcare Conference


Ron Squarer, Chief Executive Officer


Wednesday, February 10, 2016


8:00 a.m. Eastern Time


The Waldorf Astoria, New York, NY


About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to


Tricia Haugeto

Array BioPharma Inc.


Logo -


SOURCE Array BioPharma Inc.